Most important publications

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publications 2023

 

1. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment, Andrysiak K., et al., Cardiovasc Res. 2023 Dec 11:cvad182.doi: 10.1093/cvr/cvad182.

2. Single-cell transcriptomics reveals subtype-specific molecular profiles in Nrf2-deficient macrophages from murine atherosclerotic aortas, Sarad K, Stefańska M, Kraszewska I, Szade K, Sluimer J C., Błyszczuk P, Dulak J, Jaźwa-Kusior A, Front. Immunol. 2023, 14:1249379. doi: 10.3389/fimmu.2023.1249379.

3. Generation of two induced pluripotent stem cell lines from psoriatic patient with cardiovascular comorbidity, Dev E, Adamska P, Wolnik J, Oleksy A, Piętowska Z, Zalewski A, Maj J, Dulak J, Biniecka M, Stem Cell Research 2023, 103251, doi: 10.1016/j.scr.2023.103251.

4. Casein kinase 2 activity is a host restriction factor for AAV transduction, Kraszewska I, Sarad K, Andrysiak K, Kopacz A, Schmidt L, Krüger M, Dulak J, Jaźwa-Kusior A. Mol Ther. 2023 Nov 10:S1525-0016(23)00611-1. doi: 10.1016/j.ymthe.2023.11.010.

5. Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia, Florczyk-Soluch U, Polak K, Sabo R, Martyniak A, Stępniewski J, Dulak J. Pharmacol Rep. 2023 Dec;75(6):1556-1570. doi: 10.1007/s43440-023-00535-8.

6. miR-378 influences muscle satellite cells and enhances adipogenic potential of fibro-adipogenic progenitors but does not affect muscle regeneration in the glycerol-induced injury model, O. Mucha, P. Podkalicka, M. Żukowska, E. Pośpiech, J. Dulak, A. Łoboda, Scientific Reports, 2023, 13:13434. doi.org/10.1038/s41598-023-40729-x.

7. Sodium hydrosulfide moderately alleviates the hallmark symptoms of duchenne muscular dystrophy in mdx mice, M. Myszka, A. Łoboda, European Journal of Pharmacology 2023, doi. 10.1016/j.ejphar.2023.175928.

8. TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells, Rolski F, Tkacz K, Węglarczyk K, Kwiatkowski G, Pelczar P, Jaźwa-Kusior A, Bar A, Kuster GM, Chłopicki S, Siedlar M, Kania G, Błyszczuk P.,  Cardiovasc Res. 2023 Oct 25:cvad158. doi: 10.1093/cvr/cvad158.

9. Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products, M. Pecyna, J. Dulak, Stem Cell Reports, Vol. 18, 1610–1620, August 8, 2023, doi:10.1016/j.stemcr.2023.05.017.

10. Effect of heme oxygenase-1 on the differentiation of human myoblasts and the regeneration of murine skeletal muscles after acute and chronic injury, Głowniak-Kwitek U, Caballero AL, Bronisz-Budzyńska I, Kozakowska M, Andrysiak K, Stępniewski J, Łoboda A, Dulak J., Pharmacol Rep. 2023 Apr;75(2):397-410. doi: 10.1007/s43440-023-00475-3.

11. Generation of miR-15a/16-1 cluster-deficient human induced pluripotent stem cell line (DMBi001-A-2) using CRISPR/Cas9 gene editing, J. Stępniewski, M. Jeż, J. Dulak, Stem Cell Res. 2023 Apr:68:103046. doi: 10.1016/j.scr.2023.103046.

12. Nuclear Factor Erythroid 2-Related Factor 2 and Its Targets in Skeletal Muscle Repair and Regeneration, Łoboda A, Dulak J. Antioxid Redox Signal. 2023 Mar;38(7-9):619-642. doi: 10.1089/ars.2022.0208.

13. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene, Polak K, Stępniewski J, Ścieżyńska A, Podgórska A, Dulak J, Florczyk-Soluch U. Stem Cell Res. 2023 Feb;66:103004. doi: 10.1016/j.scr.2022.103004.

14. Adaptation of cardiomyogenesis to the generation and maturation of cardiomyocytes from human pluripotent stem cells, Martyniak A, Jeż M, Dulak J, Stępniewski J. IUBMB Life. 2023 Jan;75(1):8-29. doi: 10.1002/iub.2685.

15. Co-administration of angiotensin II and simvastatin triggers kidney injury upon heme oxygenase-1 deficiency, Kopacz A, Klóska D, Cysewski D, Kraszewska I, Przepiórska K, Lenartowicz M, Łoboda A, Grochot-Przęczek A, Nowak W, Józkowicz A, Piechota-Polańczyk A. Free Radic Biol Med. 2023 Aug 20;205:188-201. doi:
10.1016/j.freeradbiomed.2023.05.018.

16. Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review, Panzer B, Kopp CW, Neumayer C, Koppensteiner R, Jozkowicz A, Poledniczek M, Gremmel T, Jilma B, Wadowski PP. Cells. 2023 Jul 16;12(14):1865. doi: 10.3390/cells12141865.

17. Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease-Pathophysiology and Translational Therapeutic Approaches, Poledniczek M, Neumayer C, Kopp CW, Schlager O, Gremmel T, Jozkowicz A, Gschwandtner ME, Koppensteiner R, Wadowski PP. Biomedicines. 2023 Aug 17;11(8):2284. doi: 10.3390/biomedicines11082284.

18. Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets, Bourgonje AR, Kloska D, Grochot-Przęczek A, Feelisch M, Cuadrado A, van Goor H. Redox Biol. 2023 Apr;60:102603. doi: 10.1016/j.redox.2023.102603.

19. Microvascular Thrombosis as a Critical Factor in Severe COVID-19, Wadowski PP, Panzer B, Józkowicz A, Kopp CW, Gremmel T, Panzer S, Koppensteiner R. Int J Mol Sci. 2023 Jan 27;24(3):2492. doi: 10.3390/ijms24032492.

20. Techniki inżynierii genetycznej w terapii genowej, medycynie regeneracyjnej i transplantacyjnej, A. Łoboda, J. Dulak, Genetyka Medyczna i Molekularna, rozdział 13.2, Wydawnictwo Naukowe PWN SA Warszawa 2017, 2023 wydanie 2, https://doi.org/10.53271/2023.089.

21. Terapie komórkowe i genetyczne w dystrofii mięśniowej Duchenne'a – możliwości i ograniczenia. A. Łoboda, J. Dulak, Standardy medyczne/Pediatria, 2023, t. 20, s. 587-595, Media-Press Sp. z.o.o. ISSN: 2080-5438.

 

 

Publications 2022

 

1. NRF2 Regulates Viability, Proliferation, Resistance to Oxidative Stress, and Differentiation of Murine Myoblasts and Muscle Satellite Cells,  I. Bronisz-Budzynska, M. Kozakowska, K. Pietraszek-Gremplewicz, M. Madej, A. Józkowicz, A. Łoboda, J. Dulak, Cells 2022, 11, 3321, doi.org/10.3390/cells11203321.

2. Angiotensin II receptor 1 controls profibrotic Wnt/b-catenin signalling in experimental autoimmunemyocarditis, M. Czepiel, D. Diviani,  A. Jaźwa-Kusior, K. Tkacz, F. Rolski, R. T Smolenski, M. Siedlar, U. Eriksson, G. Kania, P. Błyszczuk, Cardiovascular Research 2022, 118, 573–584 doi:10.1093/cvr/cvab039.

3. The lack of transcriptionally active Nrf2 triggers colon dysfunction in female mice – The role of estrogens, A. Kopacz, D. Kloska, J. Fichna, D.  Klimczyk, M. Kopec, A.  Jozkowicz, A. Piechota-Polanczyk, Free Radical Biology and Medicine 192 (2022) 141–151, doi.org/10.1016/j.freeradbiomed.2022.09.014.

4. Nrf2 Transcriptional Activity Governs Intestine Development, A. Kopacz, D. Kloska, D. Klimczyk, M. Kopec, A. Jozkowicz, A. Piechota-Polanczyk, Int. J. Mol. Sci. 2022, 23, 6175., doi.org/10.3390/ijms23116175.

5. Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers, A. Kusienicka, K. Bukowska-Strakova , M. Cieśla , W. Norbert Nowak, I. Bronisz-Budzyńska, A. Seretny, M. Żukowska, M. Jez, R. Krutyhołowa, H. Taha, N. Kachamakova-Trojanowska, H. Waś, C. Kieda, A. Józkowicz, Int. J.Mol. Sci. 2022, 23, 3596. doi.org/10.3390/ijms23073596.

6. Slow-cycling murine melanoma cells display plasticity and enhanced tumorigenicity in syngeneic transplantation assay, A. Kusienicka, M. Cieśla, K. Bukowska-Strakova , W.N. Nowak, I. Bronisz-Budzyńska , A. Seretny, M. Żukowska, M. Jeż, J. Wolnik , A. Józkowicz, Neoplasia 36 (2023) 100865, doi: 10.1016/j.neo.2022.100865.

7. miR‑378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy, P. Podkalicka, O. Mucha, K. Kaziród, K. Szade, J. Stępniewski, L. Ivanishchuk, H. Hirao, E. Pośpiech, A. Józkowicz,  J. W Kupiec-Weglinski, J. Dulak, A.  Łoboda, Scientific Reports 2022, 12:3945, doi.org/10.1038/s41598-022-07868-z.

8. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene, K. Polak, J. Stępniewski,  A. Ścieżyńska, A. Podgórska, J. Dulak, Urszula Florczyk-Soluch, Stem Cell Research 66 (2023) 103004, doi.org/10.1016/j.scr.2022.103004.

9. Generation of two hiPSC lines, (DMBi003-A and DMBi004-A), by reprogramming peripheral blood mononuclear cells and fibroblast-like synoviocytes from rheumatoid arthritis patients, J. Wolnik,  G. Kubiak, M. Skoczyńska, P. Wiland, U. Fearon, D. Veale, J. Dulak, M. Biniecka, Stem Cell Research 64 (2022) 102886, doi.org/10.1016/j.scr.2022.102886.

10. Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout, O. Mucha, K.  Kaziród, P.  Podkalicka, K. Rusin, J. Dulak,  A.  Łoboda, Int. J. Mol. Sci. 2022, 23, 470. doi.org/10.3390/ijms23010470.

11. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle‑related diseases, K. Kaziród, M. Myszka, J. Dulak, A.  Łoboda, Cellular and Molecular Life Sciences (2022) 79:608, doi.org/10.1007/s00018-022-04636-0.

12. Overlooked and valuable facts to know in the NRF2/KEAP1 field, A. Kopacz, A. Piechota-Polanczyk, A. I. Rojo, C. Patibandla, D. Lastra-Martínez, D. Kloska, C. Sutherland, A. Cuadrado,  A. Jozkowicz, A. Grochot-Przeczek, Free Radical Biology and Medicine 192 (2022) 37–49, doi.org/10.1016/j.freeradbiomed.2022.08.044.

13. Molekularne mechanizmy dystrofii mięśniowej Duchenne’a i nowe możliwości terapeutyczne, P. Podkalicka, M. Myszka, J. Dulak, A. Łoboda, Postępy Biochemii 68 (2) 2022, doi.org/10.18388/pb.2021_428.

14. The biology of hematopoietic stem cells and its clinical implications,  I. Skulimowska, J. Sosniak, Monika Gonka, A. Szade, A. Jozkowicz, K.  Szade FEBS J. 2022 Dec;289(24):7740-7759. doi: 10.1111/febs.16192.

15. Cardiovascular Disease Management in the Context of Global Crisis, P. P Wadowski, A. Piechota-Polańczyk, M.  Andreas, Ch. W Kopp Int. J. Environ. Res. Public Health 2023, 20, 689. doi.org/10.3390/ijerph20010689.

16. Odpowiedzialność za stosowanie produktu leczniczego terapii zaawansowanej - wyjątku szpitalnego w ramach tzw. terapii eksperymentalnej z wykorzystaniem komórek macierzystych, M. Pecyna, J. Dulak, KWARTALNIK PRAWA PRYWATNEGO Rok XXXI: 2022, z. 4 ISSN 1230–7173.

17. Pojęcie produktu leczniczego terapii zaawansowanej - wyjątku szpitalnego w prawie unijnym a regulacja prawa polskiego na przykładzie terapii z wykorzystaniem komórek macierzystych, M. Pecyna, J. Dulak, Europejski Przegląd Sądowy listopad 2022, 12-20.

 

Publications 2021

1.    Computational Fluid Dynamic Technique for Assessment of How Changing Character of Blood Flow and Different Value of Hct Influence Blood Hemodynamic in Dissected Aorta. Polanczyk A, Piechota-Polanczyk A, Huk I, Neumayer C, Balcer J, Strzelecki M. Diagnostics (Basel). 2021 Oct 11;11(10):1866. doi: 10.3390/diagnostics11101866.

2.    The biology of hematopoietic stem cells and its clinical implications. Skulimowska I, Sosniak J, Gonka M, Szade A, Jozkowicz A, Szade K. FEBS J. 2021 Sep 8. doi: 10.1111/febs.16192

3.    Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy. Mucha O, Podkalicka P, Kaziród K, Samborowska E, Dulak J, Łoboda A. Skelet Muscle. 2021 Sep 3;11(1):21. doi: 10.1186/s13395-021-00276-3.

4.    DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis. Barzowska A, Pucelik B, Pustelny K, Matsuda A, Martyniak A, Stępniewski J, Maksymiuk A, Dawidowski M, Rothweiler U, Dulak J, Dubin G, Czarna A. Cells. 2021 Aug 31;10(9):2263. doi: 10.3390/cells10092263.

5.    Gene therapy. The legacy of Wacław Szybalski. Dulak J. Acta Biochim Pol. 2021 Aug 31;68(3):359-375. doi: 10.18388/abp.2020_5805.

6.    The multifaceted view of heart problem in Duchenne muscular dystrophy.  Florczyk-Soluch U, Polak K, Dulak J. Cell Mol Life Sci. 2021 Jul;78(14):5447-5468. doi: 10.1007/s00018-021-03862-2.

7.    Maturity Onset Diabetes of the Young-New Approaches for Disease Modelling. Skoczek D, Dulak J, Kachamakova-Trojanowska N. Int J Mol Sci. 2021 Jul 14;22(14):7553. doi: 10.3390/ijms22147553.

8.    Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.  Andrysiak K, Stępniewski J, Dulak J. Pflugers Arch. 2021 Jul;473(7):1061-1085. doi: 10.1007/s00424-021-02536-z.

9.    Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation.  Pyziak K, Sroka-Porada A, Rzymski T, Dulak J, Łoboda A. Drug Dev Res. 2021 Feb 9. doi: 10.1002/ddr.21796.

10.    Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.  Martyniak A, Andrysiak K, Motais B, Coste S, Podkalicka P, Ferdek P, Stępniewski J, Dulak J. J Mol Cell Cardiol. 2021 Jul 28;160:128-141. doi: 10.1016/j.yjmcc.2021.07.007.

11.    Role of Heme-Oxygenase-1 in Biology of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Jeż M, Martyniak A, Andrysiak K, Mucha O, Szade K, Kania A, Chrobok Ł, Palus-Chramiec K, Sanetra AM, Lewandowski MH, Pośpiech E, Stępniewski J, Dulak J. Cells. 2021 Mar 1;10(3):522. doi: 10.3390/cells10030522.

12.    Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin.  Koczurkiewicz-Adamczyk P, Klaś K, Gunia-Krzyżak A, Piska K, Andrysiak K, Stępniewski J, Lasota S, Wójcik-Pszczoła K, Dulak J, Madeja Z, Pękala E. Int J Mol Sci. 2021 Jun 9;22(12):6217. doi: 10.3390/ijms22126217.

13.    Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy. Podkalicka P, Mucha O, Kaziród K, Bronisz-Budzyńska I, Ostrowska-Paton S, Tomczyk M, Andrysiak K, Stępniewski J, Dulak J, Łoboda A. Biomedicines. 2021 Apr 27;9(5):481. doi: 10.3390/biomedicines9050481.

14.    Corrigendum to "Nrf2 transcriptional activity in the mouse affects the physiological response to tribromoethanol" [Biomed. Pharmacother. 128 (2020) 110317].  Kopacz A, Werner E, Kloska D, Nesterak S, Hajduk K, Fichna J, Jozkowicz A, Piechota-Polanczyk A. Biomed Pharmacother. 2021 Jan;133:111020. doi: 10.1016/j.biopha.2020.111020.

15.    The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases.  Piotrowska M, Swierczynski M, Fichna J, Piechota-Polanczyk A. Pharmacol Res. 2021 Jan;163:105243. doi: 10.1016/j.phrs.2020.105243.

16.    The role of heme oxygenase-1 in hematopoietic system and its microenvironment. Szade A, Szade K, Mahdi M, Józkowicz A. Cell Mol Life Sci. 2021 May;78(10):4639-4651. doi: 10.1007/s00018-021-03803-z.

17.    Proximity Ligation Assay Detection of Protein-DNA Interactions-Is There a Link between Heme Oxygenase-1 and G-quadruplexes? Krzeptowski W, Chudy P, Sokołowski G, Żukowska M, Kusienicka A, Seretny A, Kalita A, Czmoczek A, Gubała J, Baran S, Klóska D, Jeż M, Stępniewski J, Szade K, Szade A, Grochot-Przęczek A, Józkowicz A, Nowak WN. Antioxidants (Basel). 2021 Jan 12;10(1):94. doi: 10.3390/antiox10010094.

18.    A Dual Role of Heme Oxygenase-1 in Angiotensin II-Induced Abdominal Aortic Aneurysm in the Normolipidemic Mice. Kopacz A, Klóska D, Werner E, Hajduk K, Grochot-Przęczek A, Józkowicz A, Piechota-Polańczyk A. Cells. 2021 Jan 15;10(1):163. doi: 10.3390/cells10010163.

19.    Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Dumanski JP, Halvardson J, Davies H, Rychlicka-Buniowska E, Mattisson J, Moghadam BT, Nagy N, Węglarczyk K, Bukowska-Strakova K, Danielsson M, Olszewski P, Piotrowski A, Oerton E, Ambicka A, Przewoźnik M, Bełch Ł, Grodzicki T, Chłosta PL, Imreh S, Giedraitis V, Kilander L, Nordlund J, Ameur A, Gyllensten U, Johansson Å, Józkowicz A, Siedlar M, Klich-Rączka A, Jaszczyński J, Enroth S, Baran J, Ingelsson M, Perry JRB, Ryś J, Forsberg LA. Cell Mol Life Sci. 2021 Apr;78(8):4019-4033. doi: 10.1007/s00018-021-03822-w.

20.    Role of HMOX1 Promoter Genetic Variants in Chemoresistance and Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia. Bukowska-Strakova K, Włodek J, Pitera E, Kozakowska M, Konturek-Cieśla A, Cieśla M, Gońka M, Nowak W, Wieczorek A, Pawińska-Wąsikowska K, Józkowicz A, Siedlar M. Int J Mol Sci. 2021 Jan 20;22(3):988. doi: 10.3390/ijms22030988.

 

 

Publications 2020

1.    Heme oxygenase-1 deficiency triggers exhaustion of hematopoietic stem cells. Szade Krzysztof, Zukowska Monika, Szade Agata, Nowak Witold, Skulimowska Izabela, Ciesla Maciej, Bukowska-Strakova Karolina, Gulati GS, Kachamakova-Trojanowska Neli, Kusienicka Anna, Einwallner E, Kijowski J, Czauderna Szymon, Esterbauer H, Benes V, L Weissman I, Dulak Jozef, Jozkowicz Alicja. EMBO Rep. 2020 Feb 5;21(2): e47895. doi: 10.15252/embr.201947895. Epub 2019 Dec 29.

2.    Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells.  Białopiotrowicz E, Noyszewska-Kania M, Kachamakova-Trojanowska Neli, Łoboda Agnieszka, Cybulska M, Grochowska A, Kopczyński M, Mikula M, Prochorec-Sobieszek M, Firczuk M, Graczyk-Jarzynka A, Zagożdżon R, Ząbek A, Młynarz P, Dulak Józef, Górniak P, Szydłowski M, Pyziak K, Martyka J, Sroka-Porada A, Jabłońska E, Polak A, Kowalczyk P, Szumera-Ciećkiewicz A, Chapuy B, Rzymski T, Brzózka K, Juszczyński P. Cancers (Basel). 2020 Mar 3;12(3):580. doi: 10.3390/cancers12030580.

3.    Variability in Cardiac miRNA-122 Level Determines Therapeutic Potential of miRNA-Regulated AAV Vectors. Kraszewska Izabela, Tomczyk Mateusz, Andrysiak Kalina, Biniecka M, Geisler A, Fechner H, Zembala M, Stępniewski Jacek, Dulak Józef, Jaźwa-Kusior Agnieszka. Mol Ther Methods Clin Dev. 2020 May 12; 17:1190-1201. doi: 10.1016/j.omtm.2020.05.006. eCollection 2020 Jun 12.

4.    HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. Kachamakova-Trojanowska Neli, Podkalicka Paulina, Bogacz Tomasz, Barwacz Szymon, Józkowicz Alicja, Dulak Józef, Łoboda Agnieszka. Biochem Pharmacol. 2020 May; 175:113922. doi: 10.1016/j.bcp.2020.113922. Epub 2020 Mar 20.

5.    Keap1 controls protein S-nitrosation and apoptosis-senescence switch in endothelial cells.  Kopacz Aleksandra, Klóska Damian, Proniewski B, Cysewski D, Personnic Nicolas, Piechota-Polańczyk Aleksandra, Kaczara P, Zakrzewska A, Forman HJ, Dulak Józef, Józkowicz Alicja, Grochot-Przęczek Anna. Redox Biol. 2020 Jan; 28:101304. doi: 10.1016/j.redox.2019.101304. Epub 2019 Aug 22.

6.    Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes.  Podkalicka Paulina, Mucha Olga, Kruczek Szczepan, Biela Anna, Andrysiak Kalina, Stępniewski Jacek, Mikulski M, Gałęzowski M, Sitarz K, Brzózka K, Józkowicz Alicja, Dulak Józef, Łoboda Agnieszka. Biomolecules. 2020 Jan 16;10(1):143. doi: 10.3390/biom10010143.

7.    Lack of miR-378 attenuates muscular dystrophy in mdx mice. Podkalicka Paulina, Mucha Olga, Bronisz-Budzyńska Iwona, Kozakowska Magdalena, Pietraszek-Gremplewicz Katarzyna, Cetnarowska Anna, Głowniak-Kwitek Urszula, Bukowska-Strakova Karolina, Cieśla Maciej, Kulecka M, Ostrowski J, Mikuła M, Potulska-Chromik A, Kostera-Pruszczyk A, Józkowicz Alicja, Łoboda Agnieszka, Dulak Józef. JCI Insight. 2020 Jun 4;5(11): e135576. doi: 10.1172/jci.insight.135576.

8.    Effect of Heme Oxygenase-1 on Melanoma Development in Mice-Role of Tumor-Infiltrating Immune Cells.  Was Halina, Cichon T, Smolarczyk R, Lackowska B, Mazur-Bialy A, Mazur Magdalena, Szade Agata, Dominik Paweł, Mazan Milena, Kotlinowski Jerzy, Zebzda A, Kusienicka Anna, Kieda C, Dulak Józef, Jozkowicz Alicja. Antioxidants (Basel). 2020 Dec 3;9(12):1223. doi: 10.3390/antiox9121223.

9.    Characterization of hepatic macrophages and evaluation of inflammatory response in heme oxygenase-1 deficient mice exposed to scAAV9 vectors.  Tomczyk Mateusz, Kraszewska Izabela, Mąka Robert, Waligórska A, Dulak Józef, Jaźwa-Kusior Agnieszka. PLoS One. 2020 Oct 15;15(10): e0240691. doi: 10.1371/journal.pone.0240691. eCollection 2020.

10.    The role of Nrf2 in acute and chronic muscle injury.  Bronisz-Budzyńska Iwona, Kozakowska Magdalena, Podkalicka Paulina, Kachamakova-Trojanowska Neli, Łoboda Agnieszka, Dulak Józef. Skelet Muscle. 2020 Dec 8;10(1):35. doi: 10.1186/s13395-020-00255-0.

11.    Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, in Contrast to Adipose Tissue-Derived Stromal Cells, Efficiently Improve Heart Function in Murine Model of Myocardial Infarction. Stępniewski Jacek, Tomczyk Mateusz, Andrysiak Kalina, Kraszewska Izabela, Martyniak Alicja, Langrzyk Agnieszka, Kulik Klaudia, Wiśniewska Ewa, Jeż Mateusz, Florczyk-Soluch Urszula, Polak Katarzyna, Podkalicka Paulina, Kachamakova-Trojanowska Neli, Józkowicz Alicja, Jaźwa-Kusior Agnieszka, Dulak Józef. Biomedicines. 2020 Dec 7;8(12):578. doi: 10.3390/biomedicines8120578.

12.    Simvastatin Attenuates Abdominal Aortic Aneurysm Formation Favoured by Lack of Nrf2 Transcriptional Activity. Kopacz Aleksandra, Werner Ewa, Grochot-Przęczek Anna, Klóska Damian, Hajduk Karolina, Neumayer C, Józkowicz Alicja, Piechota-Polanczyk Aleksandra. Oxid Med Cell Longev. 2020 Jun 16; 2020:6340190. doi: 10.1155/2020/6340190.

13.    Keap1 governs ageing-induced protein aggregation in endothelial cells. Kopacz Aleksandra, Kloska Damian, Targosz-Korecka M, Zapotoczny B, Cysewski D, Personnic Nicolas, Werner Ewa, Hajduk Karolina, Jozkowicz Alicja, Grochot-Przeczek Anna. Redox Biol. 2020 Jul; 34:101572. doi: 10.1016/j.redox.2020.101572

14.    Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier. Targosz-Korecka M, Malek-Zietek KE, Kloska Damian, Rajfur Z, Stepien EŁ, Grochot-Przeczek Anna, Szymonski M. Biochim Biophys Acta Gen Subj. 2020 Apr;1864(4):129533. doi: 10.1016/j.bbagen.2020.129533.

15.    Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. Rozga P, Kloska Damian, Pawlak S, Teska-Kaminska M, Galazka M, Bukato K, Pieczykolan A, Jaworski A, Molga-Kaczmarska A, Kopacz Aleksandra, Badyra Bogna, Kachamakova-Trojanowska Neli, Zolnierkiewicz Olga, Targosz-Korecka M, Poleszak K, Szymanik M, Zerek B, Pieczykolan J, Jozkowicz Alicja, Grochot-Przeczek Anna. Int J Cancer. 2020 Aug 15;147(4):1117-1130. doi: 10.1002/ijc.32845.

16.    Nrf2 transcriptional activity in the mouse affects the physiological response to tribromoethanol Aleksandra Kopacz, Ewa Werner, Damian Kloska, Sylwia Nesterak, Karolina Hajduk, J. Fichna, Alicja Jozkowicz, Aleksandra Piechota-Polanczyk Biomedicine & Pharmacotherapy, Volume 128, August 2020, Pages 110317

17.    A molecular map of murine lymph node blood vascular endothelium at single cell resolution. Brulois K, Rajaraman A, Szade Agata, Nordling S, Bogoslowski A, Dermadi D, Rahman M, Kiefel H, O'Hara E, Koning JJ, Kawashima H, Zhou B, Vestweber D, Red-Horse K, Mebius RE, Adams RH, Kubes P, Pan J, Butcher EC. Nat Commun. 2020 Jul 30;11(1):3798. doi: 10.1038/s41467-020-17291-5. PubMed PMID: 32732867; PubMed Central PMCID: PMC7393069.

18.    Abdominal Aortic Aneurysm Analysis as a Useful Tool for the Estimation of Stent-Graft Migration. Polanczyk A, Piechota-Polanczyk Aleksandra, Stefańczyk L, Strzelecki M. Spatial Configuration of Diagnostics (Basel). 2020 Sep 23;10(10):737. doi: 10.3390/diagnostics10100737.

19.    Shape and Enhancement Analysis as a Useful Tool for the Presentation of Blood Hemodynamic Properties in the Area of Aortic Dissection. Polanczyk A, Piechota-Polanczyk Aleksandra, Stefanczyk L, Strzelecki M.  J Clin Med. 2020 May 2;9(5):1330. doi: 10.3390/jcm9051330.

20.    Analysis of the Effectiveness of Decontamination Fluids on the Level of Biological Contamination of Firefighter Suits. Polanczyk A, Piechota-Polanczyk Aleksandra, Dmochowska A, Majder-Lopatka M, Salamonowicz Z. Int J Environ Res Public Health. 2020 Apr 19;17(8):2815. doi: 10.3390/ijerph17082815.

21.    Exacerbation of Neonatal Hemolysis and Impaired Renal Iron Handling in Heme Oxygenase 1-Deficient Mice. Bednarz A, Lipiński P, Starzyński RR, Tomczyk Mateusz, Kraszewska Izabela, Herman S, Kowalski K, Gruca E, Jończy A, Mazgaj R, Szudzik M, Rajfur Z, Baster Z, Józkowicz Alicja, Lenartowicz M. Int J Mol Sci. 2020 Oct 20;21(20):7754. doi: 10.3390/ijms21207754.

22.    Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis. Zarak-Crnkovic, M., Kania, G., Jaźwa-Kusior, A. et al. Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis. Basic Res Cardiol 115, 6 (2020). https://doi.org/10.1007/s00395-019-0766-6

23.    Ageing hallmarks exhibit organ-specific temporal signatures. Schaum N, Lehallier B, Hahn O, Pálovics R, Hosseinzadeh S, Lee SE, Sit R, Lee DP, Losada PM, Zardeneta ME, Fehlmann T, Webber JT, McGeever A, Calcuttawala K, Zhang H, Berdnik D, Mathur V, Tan W, Zee A, Tan M; Tabula Muris Consortium, Pisco AO, Karkanias J, Neff NF, Keller A, Darmanis S, Quake SR, Wyss-Coray T. Nature. 2020 Jul;583(7817):596-602. doi: 10.1038/s41586-020-2499-y. Epub 2020 Jul 15.

24.    A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Tabula Muris Consortium. Nature. 2020 Jul;583(7817):590-595. doi: 10.1038/s41586-020-2496-1. Epub 2020 Jul 15.   

25.    Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Łoboda Agnieszka, Dulak Józef. Pharmacol Rep. 2020 Oct;72(5):1227-1263. doi: 10.1007/s43440-020-00134-x. Epub 2020 Jul 20.

26.    Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells. Podkalicka Paulina, Stępniewski Jacek, Mucha Olga, Kachamakova-Trojanowska Neli, Dulak Józef, Łoboda Agnieszka. Biomolecules. 2020 Nov 29;10(12):1614. doi: 10.3390/biom10121614.

27.    Beyond repression of Nrf2: An update on Keap1. Kopacz Aleksandra, Kloska Damian, Forman HJ, Jozkowicz Alicja, Grochot-Przeczek Anna. Free Radic Biol Med. 2020 Sep;157:63-74. doi: 10.1016/j.freeradbiomed.2020.03.023.

28.    Komórki macierzyste w medycynie: możliwości, nadzieje, kontrowersje, M Biniecka, K Kulik, A Langrzyk, E Wiśniewska, Józef Dulak, Medycyna po Dyplomie, styczeń 2019, https://podyplomie.pl/medycyna/32313,komorki-macierzyste-w-medycynie-mozliwosci-nadzieje-kontrowersje.

29.    Komórki macierzyste: zastosowania, perspektywy, nieporozumienia, Józef Dulak NAUKA1/2020, 99 -123, doi:10.24425/nauka.2020.132624   

30.    Światopogląd naukowy biotechnologa, Józef Dulak Rocznik „NAUKA POLSKA JEJ POTRZEBY, ORGANIZACJA I ROZWÓJ” ,Tom XXIX (LIV) 2020.

31.    The fundamental discoveries in oxygen sensing: implications for heart diseases and cardiomyocytes maturation, Monika Biniecka, Jan Wolnik, Józef Dulak Kwartalnik KOSMOS, Polskie Towarzystwo Przyrodników im. Kopernika Tom 69 Nr 4 (2020): Fizjologia wysiłku fizycznego, Strony 563–577.

32.    Progress in heme oxygenase research.  Surh YJ, Chung HT, Na HK, Dulak Józef, Stec DE. Arch Biochem Biophys. 2020 May 30; 685:108321. doi: 10.1016/j.abb.2020.108321. Epub 2020 Feb 24.

 

 

Publications 2019

  • Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young. Kachamakova-Trojanowska N, Stepniewski J, Dulak J. Cells. 2019 Nov 14;8(11). pii: E1440. doi: 10.3390/cells8111440.
  • Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood. Szade A, Szade K, Nowak WN, Bukowska-Strakova K, Muchova L, Gońka M, Żukowska M, Cieśla M, Kachamakova-Trojanowska N, Rams-Baron M, Ratuszna A, Dulak J, Józkowicz A. EMBO Mol Med. 2019 Dec;11(12):e09571. doi: 10.15252/emmm.201809571.
  • Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells. Klóska D, Kopacz A, Piechota-Polańczyk A, Neumayer C, Huk I, Dulak J, Józkowicz A, Grochot-Przęczek A. Arch Biochem Biophys. 2019 Dec 15;678:108182. doi: 10.1016/j.abb.2019.108182.
  • miR-378a influences vascularization in skeletal muscles. Krist B, Podkalicka P, Mucha O, Mendel M, Sępioł A, Rusiecka OM, Józefczuk E, Bukowska-Strakova K, Grochot-Przęczek A, Tomczyk M, Klóska D, Giacca M, Maga P, Niżankowski R, Józkowicz A, Łoboda A, Dulak J, Florczyk-Soluch U. Cardiovasc Res. 2019 Aug 28. pii: cvz236. doi: 10.1093/cvr/cvz236.
  • miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Bronisz-Budzyńska I, Chwalenia K, Mucha O, Podkalicka P, Karolina-Bukowska-Strakova, Józkowicz A, Łoboda A, Kozakowska M, Dulak J. Skelet Muscle. 2019 Aug 14;9(1):22. doi: 10.1186/s13395-019-0207-0.
  • Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity In Vitro but Not In Vivo. Nowak WN, Taha H, Markiewicz J, Kachamakova-Trojanowska N, Stępniewski J, Klóska D, Florczyk-Soluch U, Niżankowski R, Frołow M, Walter Z, Dulak J, Józkowicz A. Mediators Inflamm. 2019 Jul 16;2019:1868170. doi: 10.1155/2019/1868170.
  • Single-Cell RNA-Sequencing and Metabolomics Analyses Reveal the Contribution of Perivascular Adipose Tissue Stem Cells to Vascular Remodeling. Gu W, Nowak WN, Xie Y, Le Bras A, Hu Y, Deng J, Issa Bhaloo S, Lu Y, Yuan H, Fidanis E, Saxena A, Kanno T, Mason AJ, Dulak J, Cai J, Xu Q. Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2049-2066. doi: 10.1161/ATVBAHA.119.312732.
  • Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment. Mucha O, Podkalicka P, Mikulski M, Barwacz S, Andrysiak K, Biela A, Mieczkowski M, Kachamakova-Trojanowska N, Ryszawy D, Białas A, Szelążek B, Grudnik P, Majewska E, Michalik K, Jakubiec K, Bień M, Witkowska N, Gluza K, Ekonomiuk D, Sitarz K, Gałęzowski M, Brzózka K, Dubin G, Józkowicz A, Dulak J, Łoboda A. Arch Biochem Biophys. 2019 Aug 15;671:130-142. doi: 10.1016/j.abb.2019.07.002.
  • Targeting angiogenesis in Duchenne muscular dystrophy. Podkalicka P, Mucha O, Dulak J, Loboda A. Cell Mol Life Sci. 2019 Apr;76(8):1507-1528. doi: 10.1007/s00018-019-03006-7.
  • Transcriptomes of human mesenchymal cells isolated from the right ventricle and epicardial fat differ strikingly both directly after isolation and long-term culture. Stępniewski J, Florczyk-Soluch U, Szade K, Bukowska-Strakova K, Czapla J, Matuszczak S, Jarosz-Biej M, Langrzyk A, Tomczyk M, Rumieńczyk I, Kulecka M, Mikuła M, Ostrowski J, Jaźwa-Kusior A, Zembala M, Józkowicz A, Zembala MO, Dulak J. ESC Heart Fail. 2019 Apr;6(2):351-361. doi: 10.1002/ehf2.12397.
  • Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1. Tomczyk M, Kraszewska I, Dulak J, Jazwa-Kusior A.Vascul Pharmacol. 2019 Jan;112:79-90. doi: 10.1016/j.vph.2018.08.011.
  • Nrf2 in aging - Focus on the cardiovascular system. Kloska D, Kopacz A, Piechota-Polanczyk A, Nowak WN, Dulak J, Jozkowicz A, Grochot-Przeczek A. Vascul Pharmacol. 2019 Jan;112:42-53. doi: 10.1016/j.vph.2018.08.009.
  • Nrf2 Sequesters Keap1 Preventing Podosome Disassembly: A Quintessential Duet Moonlights in Endothelium. Kloska D, Kopacz A, Cysewski D, Aepfelbacher M, Dulak J, Jozkowicz A, Grochot-Przeczek A. Antioxid Redox Signal. 2019 May 10;30(14):1709-1730. doi: 10.1089/ars.2018.7505.

 

Publications 2018

  • Daily Regulation of Phototransduction, Circadian Clock, DNA Repair, and Immune Gene Expression by Heme Oxygenase in the Retina of Drosophila. Damulewicz M, Świątek M, Łoboda A, Dulak J, Bilska B, Przewłocki R, Pyza E. Genes (Basel). 2018 Dec 21;10(1). pii: E6.
  • Kidney injury by cyclosporine A is aggravated in heme oxygenase-1 deficient mice and involves regulation of microRNAs., Loboda A, Mucha O, Podkalicka P, Sobczak M, Miksza-Cybulska A, Kaczara P, Jozkowicz A, Dulak J Acta Biochim Pol., 2018 Nov 27;65(4):613-620
  • Heme Oxygenase-1 May Affect Cell Signalling via Modulation of Ganglioside Composition., Šmíd V,  Šuk J,1 Kachamakova-Trojanowska N, Jašprová J, Valášková P, Józkowicz A, Dulak J, Šmíd F, Vítek L, Muchová L, Oxid Med Cell Longev, 2018 Sep 19;2018:3845027.
  • Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1, Tomczyk M, Kraszewska I, Dulak J, Jazwa-Kusior A, Vascul Pharmacol, 2018 Sep 10. pii: S1537-1891(18)30115-0
  • Nrf2 Sequesters Keap1 Preventing Podosome Disassembly: A Quintessential Duet Moonlights in Endothelium, Kloska D, Kopacz A,  Cysewski D, Aepfelbacher M, Dulak J, Jozkowicz A, Grochot-Przeczek A, Antioxid Redox Signal, 2018 Oct 25 doi:10.1089/ars.2018.7505.  
  • Nrf2 in aging - Focus on the cardiovascular system. Kloska D, Kopacz A, Piechota-Polanczyk A, Nowak W, Dulak J, Jozkowicz A, Grochot-Przeczek A. Vascul Pharmacol. 2018 Aug 28. pii: S1537-1891(18)30114-9.
  • Molecular profiling of regulatory T cells in pulmonary sarcoidosis. Kachamakova-Trojanowska N, Jazwa-Kusior A, Szade K, Kasper L, Soja J, Andrychiewicz A, Jakiela B, Plutecka H, Sanak M, Jozkowicz A, Sladek K, Dulak J. J Autoimmun. 2018 Jul 23. pii: S0896-8411(18)30237-3.
  • Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis.  Florczyk-Soluch U, Józefczuk E, Stępniewski J, Bukowska-Strakova K, Mendel M, Viscardi M, Nowak WN, Józkowicz A, Dulak J.  Sci Rep. 2018 Jul 17;8(1):10797.
  •  Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2. Piechota-Polanczyk A, Kopacz A, Kloska D, Zagrapan B, Neumayer C, Grochot-Przeczek A, Huk I, Brostjan C, Dulak J, Jozkowicz A. Oxid Med Cell Longev. 2018 Mar 0;2018:2028936.
  • Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles. Sobuś A, Baumert B, Litwińska Z, Gołąb-Janowska M, Stępniewski J, Kotowski M, Pius-Sadowska E, Kawa MP, Gródecka-Szwajkiewicz D, Peregud-Pogorzelski J, Dulak J, Nowacki P, Machaliński B. Int J Mol Sci. 2018 Apr 27;19(5). pii: E1312.
  • Pharmacological versus genetic inhibition of heme oxygenase-1 - the comparison of metalloporphyrins, shRNA and CRISPR/Cas9 system. Mucha O, Podkalicka P, Czarnek M, Biela A, Mieczkowski M, Kachamakova-Trojanowska N, Stepniewski J, Jozkowicz A, Dulak J, Loboda A. Acta Biochim Pol. 2018;65(2):277-286.
  • Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.  Pietraszek-Gremplewicz K, Kozakowska M, Bronisz-Budzynska I, Ciesla M, Mucha O, Podkalicka P, Madej M, Glowniak U, Szade K, Stepniewski J, Jez M, Andrysiak K, Bukowska-Strakova K, Kaminska A, Kostera-Pruszczyk A, Jozkowicz A, Loboda A, Dulak J. Antioxid Redox Signal. 2018 Jul 10;29(2):128-148.
  • Heme oxygenase inhibition in cancers: possible tools and targets. Podkalicka P, Mucha O, Józkowicz A, Dulak J, Łoboda A. Contemp Oncol (Pozn). 2018 Mar;22(1A):23-32.
  • Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells. Stepniewski J, Pacholczak T, Skrzypczyk A, Ciesla M, Szade A, Szade K, Bidanel R, Langrzyk A, Grochowski R, Vandermeeren F, Kachamakova-Trojanowska N, Jez M, Drabik G, Nakanishi M, Jozkowicz A, Dulak J. IUBMB Life. 2018 Feb;70(2):129-142.
  • Lack of Heme Oxygenase-1 Induces Inflammatory Reaction and Proliferation of Muscle Satellite Cells after Cardiotoxin-Induced Skeletal Muscle Injury. Kozakowska M, Pietraszek-Gremplewicz K, Ciesla M, Seczynska M, Bronisz-Budzynska I, Podkalicka P, Bukowska-Strakova K, Loboda A, Jozkowicz A, Dulak J. Am J Pathol. 2018 Feb;188(2):491-506. doi: 10.1016/j.ajpath.2017.10.017.

 

Publications 2017

  • Splenic Ly6Chi monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice. Tomczyk M, Kraszewska I, Szade K, Bukowska-Strakova K, Meloni M, Jozkowicz A, Dulak J, Jazwa A. Basic Res Cardiol. 2017 Jul;112(4):39
  • Nrf2 deficiency exacerbates ochratoxin A-induced toxicity in vitro and in vivo. Loboda A, Stachurska A, Sobczak M, Podkalicka P, Mucha O, Jozkowicz A, Dulak J. Toxicology. 2017 Jul 12;389:42-52
  • Haeme oxygenase protects against UV light DNA damages in the retina in clock-dependent manner. Damulewicz M, Loboda A, Jozkowicz A, Dulak J, Pyza E. Sci Rep. 2017 Jul 12;7(1):5197
  • A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection. Klimkiewicz K, Weglarczyk K, Collet G, Paprocka M, Guichard A, Sarna M, Jozkowicz A, Dulak J, Sarna T, Grillon C, Kieda C. Cancer Lett. 2017 Jun 28;396:10-20
  • MCPIP1 contributes to clear cell renal cell carcinomas development. Ligeza J, Marona P, Gach N, Lipert B, Miekus K, Wilk W, Jaszczynski J, Stelmach A, Loboda A, Dulak J, Branicki W, Rys J, Jura J. Angiogenesis. 2017 Aug;20(3):325-340
  • Valproic acid downregulates heme oxygenase-1 independently of Nrf2 by increasing ubiquitination and proteasomal degradation. Jez M, Ciesla M, Stepniewski J, Langrzyk A, Muchova L, Vitek L, Jozkowicz A, Dulak J. Biochem Biophys Res Commun. 2017 Mar 25;485(1):160-166
  • Effect of heme oxygenase-1 on ochratoxin A-induced nephrotoxicity in mice. Loboda A, Stachurska A, Podkalicka P, Sobczak M, Mucha O, Witalisz-Siepracka A, Jozkowicz A, Dulak J. Int J Biochem Cell Biol. 2017 Mar;84:46-57

 

Publications 2016

  • The influence of lipoic acid on caveolin-1-regulated antioxidative enzymes in the mouse model of acute ulcerative colitis. Piechota-Polanczyk A, Zielińska M, Piekielny D, Fichna J  Biomed Pharmacother 2016, 84: 470-475
  • Heme oxygenase 1 affects granulopoiesis in mice through control of myelocyte proliferation. Bukowska-Strakova K, Ciesla M, Szade K, Nowak WN, Straka R, Szade A, Tyszka-Czochara M, Najder K, Konturek A, Siedlar M, Dulak J, Jozkowicz A. Immunobiology. 2016 Oct 21. pii: S0171-2985(16)30426-0
  • Vascular biology: New mechanisms and pathways. Dulak J, Alexander MY, Randi AM. Vascul Pharmacol. 2016; 86:1-2
  • Many roles for Pax7. Dulak J. Cell Cycle. 2016 Oct 20:1-2
  • Limb ischemia and vessel regeneration: Is there a role for VEGF? Jazwa A, Florczyk U, Grochot-Przeczek A, Krist B, Loboda A, Jozkowicz A, Dulak J. Vascul Pharmacol. 2016; 86:18-30
  • Limb ischemia and vessel regeneration: Is there a role for VEGF? Jazwa A, Florczyk U, Grochot-Przeczek A, Krist B, Loboda A, Jozkowicz A, Dulak J. Vascul Pharmacol. 2016 Sep 10, in press
  • TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation. Loboda A, Sobczak M, Jozkowicz A, Dulak J. Mediators Inflamm. 2016; 2016: 8319283
  • Generation of functional endothelial cells with progenitor-like features from murine induced pluripotent stem cells. Kachamakova-Trojanowska N, Nowak W, Szade K, Stepniewski J, Bukowska-Strakova K, Zukowska M, Taha H, Chmura-Skirlinska A, Beilharz M, Dulak J, Jozkowicz A. Vascul Pharmacol. 2016; 86: 94-108
  • Heme oxygenase-1 controls an HDAC4-miR-206 pathway of oxidative stress in rhabdomyosarcoma. Ciesla M, Marona P, Kozakowska M, Jez M, Seczynska M, Loboda A, Bukowska-Strakova K, Szade A, Walawender M, Kusior M, Stepniewski J, Szade K, Krist B, Yagensky O, Urbanik A, Kazanowska B, Dulak J, Jozkowicz A. Cancer Res. 2016; 76: 5707-5718
  • Interactions Between the Circadian Clock and Heme Oxygenase in the Retina of Drosophila melanogaster. Damulewicz M, Loboda A, Jozkowicz A, Dulak J, Pyza E. Mol Neurobiol. 2016 Aug 13, in press
  • Analysis of Cell Cycle Status of Murine Hematopoietic Stem Cells. Szade K, Bukowska-Strakova K, Zukowska M, Jozkowicz A, Dulak J. Methods Mol Biol. 2016; 1516: 91-99
  • Measuring ATP Concentration in a Small Number of Murine Hematopoietic Stem Cells. Szade K, Zukowska M, Jozkowicz A, Dulak J. Methods Mol Biol. 2016; 1516: 205-217
  • Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Cell Mol Life Sci. 2016; 73: 3221-3247
  • Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo. Gabrysiak M, Wachowska M, Barankiewicz J, Pilch Z, Ratajska A, Skrzypek E, Winiarska M, Domagala A, Rygiel TP, Jozkowicz A, Boon L, Golab J, Firczuk M. Oncol Rep. 2016; 35: 3151-3158
  • The role of statins in heme oxygenase-1 activation in cardiovascular diseases. Piechota-Polanczyk A, Jozkowicz A. Curr Drug Targets. 2016 Apr 1, in press.
  • Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. Lis GJ, Czubek U, Jasek-Gajda E, Łoboda A, Dulak J, Nessler J, Kapelak B, Sadowski J, Litwin JA. Pol Arch Med Wewn. 2016; 126: 149-58
  • Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder Cancer. Kozakowska M, Dobrowolska-Glazar B, Okoń K, Józkowicz A, Dobrowolski Z, Dulak J. J Clin Med. 2016; 5: E29

 

Publications 2015

  • The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology. Krist B, Florczyk U, Pietraszek-Gremplewicz K, Józkowicz A, Dulak J. Int J Endocrinol. 2015; 2015: 281756
  • The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes. Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J. J Muscle Res Cell Motil. 2015; 36: 377-393
  • Heme oxygenase-1 - more than the cytoprotection. Kozakowska M, Dulak J, Józkowicz A. Postepy Biochem. 2015; 61: 147-158
  • Involvement of microRNAs in the inflammatory pathways of pulmonary sarcoidosis. Bak M, Jazwa A, Kasper L, Kachamakova-Trojanowska N, Jozkowicz A, Sladek K, Dulak J. J Physiol Pharmacol. 2015; 66: 635-642
  • Letter by Loboda et al Regarding Article, "Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis": IL-8 Is Not Present in Murine Genome Hence it Cannot Be Responsible for the Bach1 Effect on Angiogenesis in Mice. Loboda A, Florczyk U, Jazwa A, Grochot-Przeczek A, Nowak W, Jozkowicz A, Dulak J. Circ Res. 2015; 117: e75-76
  • Clock and clock-controlled genes are differently expressed in the retina, lamina and in selected cells of the visual system of Drosophila melanogaster. Damulewicz M, Loboda A, Bukowska-Strakova K, Jozkowicz A, Dulak J, Pyza E. Front Cell Neurosci. 2015; 9: 353
  • Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases. Tertil M, Golda S, Skrzypek K, Florczyk U, Weglarczyk K, Kotlinowski J, Maleszewska M, Czauderna S, Pichon C, Kieda C, Jozkowicz A, Dulak J. Free Radic Biol Med. 2015; 89: 147-157
  • HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy. Loboda A, Jozkowicz A, Dulak J. Vascul Pharmacol. 2015, 74: 11-22
  • Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo. Szade K, Zukowska M, Szade A, Collet G, Kloska D, Kieda C, Jozkowicz A, Dulak J. Tumour Biol. 2015 Sep 18. in press
  • The real face of endothelial progenitor cells - Circulating angiogenic cells as endothelial prognostic marker? Kachamakova-Trojanowska N, Bukowska-Strakova K, Zukowska M, Dulak J, Jozkowicz A. Pharmacol Rep. 2015; 67: 793-802.
  • Adult stem cells: hopes and hypes of regenerative medicine. Dulak J, Szade K, Szade A, Nowak W, Józkowicz A. Acta Biochim Pol. 2015; 62: 329-337
  • Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329-337). Loboda A, Józkowicz A, Dulak J. Thromb Haemost. 2015; 114: 432-433.
  • Cellular and molecular mechanisms of inflammation-induced angiogenesis. Szade A, Grochot-Przeczek A, Florczyk U, Jozkowicz A, Dulak J. IUBMB Life. 2015; 67: 145-159
  • Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice. Kozakowska M, Kotlinowski J, Grochot-Przeczek A, Ciesla M, Pilecki B, Derlacz R, Dulak J, Jozkowicz A. Stem Cell Res Ther. 2015; 6: 61
  • HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - effects modified by concomitant VEGF overexpression. Jazwa A, Stoszko M, Tomczyk M, Bukowska-Strakova K, Pichon C, Jozkowicz A, Dulak J. Vascul Pharmacol. 2015; 71:127-138
  • Effect of Crossing C57BL/6 and FVB Mouse Strains on Basal Cytokine Expression. Szade A, Nowak WN, Szade K, Gese A, Czypicki R, Waś H, Dulak J, Józkowicz A. Mediators Inflamm. 2015: 762419
  • Induced pluripotent stem cells as a model for diabetes investigation. Stepniewski J, Kachamakova-Trojanowska N, Ogrocki D, Szopa M, Matlok M, Beilharz M, Dyduch G, Malecki MT, Jozkowicz A, Dulak J. Sci Rep. 2015; 5: 8597
  • Comment on "Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cells". Loboda A, Jozkowicz A, Dulak J. Toxicology. 2015; 328: 82-83
  • Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis. Jazwa A, Kasper L, Bak M, Sobczak M, Szade K, Jozkowicz A, Sladek K, Dulak J.  Arch Immunol Ther Exp (Warsz), 2015; 63: 139-146

 

Publications 2014

  • PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors. Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A. Cardiovasc Diabetol. 2014; 13: 150
  • Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves. Lis GJ, Czubek U, Jasinska M, Jasek E, Loboda A, Dulak J, Nessler J, Sadowski J, Litwin JA. J Physiol Pharmacol. 2014;65: 377-382
  • Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome. Nowak WN, Borys S, Kusińska K, Bukowska-Strakova K, Witek P, Koblik T, Józkowicz A, Małecki MT, Dulak J. J Diabetes Investig. 2014; 5: 99-107
  • MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development. Cieśla M, Dulak J, Józkowicz A. Int J Biochem Cell Biol. 2014; 53C: 482-492
  • Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1. Tertil M, Skrzypek K, Florczyk U, Weglarczyk K, Was H, Collet G, Guichard A, Gil T, Kuzdzal J, Jozkowicz A, Kieda C, Pichon C, Dulak J. PLoS One. 2014; 9: e97070
  • Comment on: The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues. Szade K, Bukowska-Strakova K, Nowak WN, Jozkowicz A, Dulak J. Stem Cells Dev. 2014; 23: 714-716
  • Novel faces of heme oxygenase-1: mechanisms and therapeutic potentials. Dulak J, Jozkowicz A. Antioxid Redox Signal. 2014; 20: 1673-1676
  • Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, Volger OL, Bukowska-Strakova K, Florczyk U, Tertil M, Jazwa A, Szade K, Stepniewski J, Loboda A, Horrevoets AJ, Dulak J, Jozkowicz A. Antioxid Redox Signal. 2014; 20: 1677-1692
  • Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth. Collet G, Lamerant-Fayel N, Tertil M, El Hafny-Rahbi B, Stepniewski J, Guichard A, Foucault-Collet A, Klimkiewicz K, Petoud S, Matejuk A, Grillon C, Jozkowicz A, Dulak J, Kieda C Mol Cancer Ther. 2014; 13: 165-178
  • Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs. Kozakowska M, Szade K, Dulak J, Jozkowicz A. Antioxid Redox Signal. 2014;20: 1827-1850
  • Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia. Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda A, Dulak J. Antioxid Redox Signal. 2014; 20:1693-1708
  • Chapters in the book: Angiogenesis and vascularisation – cellular and molecular mechanisms in health and diseases, Edited by Józef Dulak, Alicja Józkowicz, Agnieszka Łoboda, Publisher: Springer, 2014, ISBN: 978-3-7091-1427-8:
  1. Endothelial cell origin, differentiation, heterogeneity and function Grochot-Przęczek A, Kozakowska M, Dulak J, Józkowicz A.
  2. Nrf2 transcription factor and heme oxygenase-1 as modulators of vascular injury and angiogenesis Florczyk U, Józkowicz A, Dulak J.
  3. Molecular mechanisms of hypoxia-regulated angiogenesis. Łoboda A, Józkowicz A, Dulak J.
  4. Signaling and structural abnormalities in tumor angiogenesis. Tertil M, Skrzypek K, Łoboda A.

 

The list of our publications from 1997 to 2013 is available at the old website: http://biotka.mol.uj.edu.pl/zbm/index.php?tresc=publications